おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Pontifax
company
About
Pontifax is a venture capital firm that finances pharmaceutical and life sciences companies.
- 1 - 10
Highlights
Details
- Industries
- Biotechnology,Medical Device,Pharmaceutical,Venture Capital
- Founded date
- Jan 1, 2004
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- Venture Capital
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Investments
Number of Investments
Number of Lead Investments
6
1
Pontifax has made 6 investments. Their most recent investment was on
Sep 14, 2020, when Neogene Therapeutics raised $110M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Sep 14, 2020
Neogene Therapeutics
|
Series A | $110M | Biotechnology | — |
|
Jul 14, 2020
ProQR Therapeutics
|
Post-IPO Debt | $30M | Biotechnology | Yes |
|
Jan 11, 2020
PACT Pharma
|
Series C | $75M | Biotechnology | — |
|
Sep 2, 2019
Adicet Bio
|
Series B | $80M | Biopharma | — |
|
Nov 8, 2017
ArQule
|
Post-IPO Equity | $9.50M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
